GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » AP Biosciences Inc (ROCO:6945) » Definitions » Research & Development

AP Biosciences (ROCO:6945) Research & Development : NT$365.95 Mil (TTM As of Dec. 2024)


View and export this data going back to 2023. Start your Free Trial

What is AP Biosciences Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. AP Biosciences's Research & Development for the six months ended in Dec. 2024 was NT$165.58 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Dec. 2024 was NT$365.95 Mil.

AP Biosciences Research & Development Historical Data

The historical data trend for AP Biosciences's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

AP Biosciences Research & Development Chart

AP Biosciences Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24
Research & Development
0.07 173.81 262.68 336.60 365.95

AP Biosciences Semi-Annual Data
Dec20 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Research & Development Get a 7-Day Free Trial 114.61 106.49 230.11 200.38 165.58

AP Biosciences Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Dec. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was NT$365.95 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

AP Biosciences  (ROCO:6945) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

AP Biosciences Research & Development Related Terms

Thank you for viewing the detailed overview of AP Biosciences's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.

AP Biosciences Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » AP Biosciences Inc (ROCO:6945) » Definitions » Research & Development
Comparable Companies
TPE:6794 ROCO:1777 ROCO:3176 ROCO:6808 TPE:6838 ROCO:6986 ROCO:8279 ROCO:06891 ROCO:6733 ROCO:6864 VRTX ASX:CSL REGN XKRX:207940 XBRU:ARGX ALNY XBRU:UCB ONC BNTX XKRX:068270
Traded in Other Exchanges
N/A
Address
No. 3, Park Street, 17th Floor, Taipei, TWN
Website
https://www.apbioinc.com
AP Biosciences Inc is a clinical-stage bispecific antibody new drug research and development company. It has developed a series of antibody and protein lead drugs through a self-designed technology platform for unmet medical needs, focusing on Specific targets associated with diseases to deliver safe, effective and cost-effective medicines.

AP Biosciences Headlines

No Headlines